Streptomycinsulfat, ≥650 u/mg, weiß, Pulver

Lieferant: MP Biomedicals
Achtung

ICNA0210055650EA 68.4 EUR
ICNA0210055650 ICNA0210055691 ICNA0210055680 ICNA0210055605
Streptomycinsulfat, ≥650 u/mg, weiß, Pulver
Streptomycin sulphate

Streptomycin sulphate is an aminoglucoside antibiotic in which streptidine is linked glycosidically to the disaccharide streptobiosamine. It is used to inhibit bacterial protein synthesis at the level of initiation inhibition. It inhibits gram-negative and gram-positive bacteria.


Mode of action: Inhibits prokaryote protein synthesis, binds to S12 protein of 30S ribosomal subunit, preventing the transition from initiation complex to chain-elongating ribosome, causing miscoding or inhibiting initiation. Mode of Resistance: Mutation in rpsL (gene for S12 ribosomal protein) prevents binding of streptomycin to ribosome. Aminoglycoside phosphotransferase also inactivates. Antimicrobial spectrum: Gram-negative and Gram-positive bacteria.


Soluble in 4% aq soln, clear, colourless solution. Stock solutions should be sterile filtered and stored at 2 to 8 °C for up to one month or aliquoted and stored at −20°C for up to 4 to 6 months.

Formel: C₂₁H₃₉N₇O₁₂·1.5H₂SO₄
Molecular Weight: 1457,4 g/mol
Schmelzpunkt: 250 °C
Lagertemperatur: Kühlschrank
MDL: MFCD00037023
CAS-Nummer: 3810-74-0
EINECS: 223-286-0
UN: 2811
ADR: 6.1,III
Merck Index: 12,08983

Bestellen

Spezifikation Testergebnisse

Identity Test Passes
Activity 766 IU/mg (Dry basis)
FTIR Conforms to Standard
Loss on Drying 4.33%
Solubility (4% aq soln) Clear, Colorless Solution
pH 5.8
Streptomycin B <3.0%
Sulfated Ash 0.3%
Sulfate 19.4%
Colorimetric Test 98.2%
Bacterial Endotoxins <0.25 IU/mg
Abnormal Toxicity 1mg/0.5ml
Sterility Passes
Sodium Metabisulfate 0.012%

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR